Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
08 Novembre 2024 - 10:06PM
Edgar (US Regulatory)
2510 Conway Ave E. Building 275-6W-20
St. Paul, MN 55144
November 7, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: Notice of disclosure filed in Exchange Act Quarterly Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Solventum Corporation has made disclosure pursuant to those provisions in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 which was filed with the Securities and Exchange Commission on November 7, 2024.
| | | | | | | | | | | | | | | | | |
| | | | | |
| |
| Respectfully submitted, | |
| /s/ Matthew M. Rice | |
| Matthew M. Rice | |
| Vice President, Associate General Counsel & Assistant Secretary | |
| Solventum Corporation | | | |
Grafico Azioni Solventum (NYSE:SOLV)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Solventum (NYSE:SOLV)
Storico
Da Gen 2024 a Gen 2025
